MBX Biosciences Inc. – Filings and Transcripts

NASDAQ: MBX
Share price (11/6/26): $51.35
Market cap (11/6/26): $2.473 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Automatic shelf registration

Registration of securities for employees

Shelf registration

Prospectus supplement with pricing info

Addition of securities to prior initial registration

Ownership Filter

Azoulay Salomon

Azoulay Salomon

News Filter

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults With Hypoparathyroidism

Reports Second Quarter 2026 Financial Results and Corporate Highlights

Change in Directors, Officers or Compensation

Announces One-Year Data Demonstrating Sustained Benefit of Once-Weekly Canvuparatide as a Potential PTH Replacement Therapy in Chronic Hypoparathyroidism

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Notice of effectiveness

Correspondence with the SEC